Patents tracker

The following IP practice note provides comprehensive and up to date legal information covering:

  • Patents tracker
  • Brexit and intellectual property rights
  • Legislation
  • Judgments—Supreme Court
  • Judgments—Court of Appeal
  • Judgments—High Court
  • Judgments—Intellectual Property Enterprise Court (IPEC)
  • Judgments—Court of Justice of the European Union
  • Consultations
  • Open consultations
  • More...

Patents tracker

This Practice Note is intended to be used to track the progress of judgments, legislative proposals and consultations related to patents.

Jump to:

  1. Legislation

  2. Judgments—Supreme Court

  3. Judgments—Court of Appeal

  4. Judgments—High Court

  5. Judgments—Intellectual Property Enterprise Court (IPEC)

  6. Judgments—Court of Justice of the European Union

  7. Consultations

For archived items on patents, see Practice Note: Patents tracker [Archived].

Brexit and intellectual property rights

The impact of Brexit on IP rights is explored in detail in the Practice Note: What does IP completion day mean for intellectual property?

For further practical guidance on the legal and practical implications of Brexit across a range of practice areas, see: Brexit toolkit.


What's happening?When?Find out more
Regulation (EU) 2019/933 amending Regulation (EC) 469/2009 concerning the supplementary protection certificates (SPCs) for medicinal products1 July 2019: Entered into forceFollowing a 2017 consultation (see European Commission consultation on SPCs), the European Commission proposed a targeted adjustment to the SPC regime: the so-called ‘export manufacturing waiver’. In the future, EU-based companies will be entitled to manufacture a generic or biosimilar version of an SPC-protected medicine during the term of the certificate, if done exclusively for the purpose of exporting to a non-EU market where protection has expired or never existed.
For further information, see the Commission press release and the Eurlex procedure file.
The UK Intellectual Property Office (IPO) launched a consultation on

Popular documents